2021/8/7~8/8 The 2021 International Kaohsiung Liver Forum 

Welcome Address                                                     Distinguished Guest

  

Keynote Lecture(I) Unmet need of HBV management           Functional cure of hepatitis B

   

Basic studies of HBV                                                  New advance in HBV and HCV coinfection

   

Keynote Lecture(II) Toward global HCV elimination       Extrahepatic manifestation after HCV cure

                         

Gap toward HCV elimination                               Unmet need of medical Treatment of HCV infection       

      

Oral Presentation

           

   

                     

   

Closing Remarks & Welcome Address                         MAFLD:New Concept and Clinical Implications    

   

Advance in the pathology of metabolic fatty liver disease

Keynote Lecture(III)

Leveraging Energy Expenditure in the Management of Non-Alcoholic Fatty Liver Disease

Keynote Lecture(IV)

Impact of dietary fat on the steatosis-associated liver tumorigenesis

Update of systemic therapy for HCC

Emerging advance of immunotherapy-based strategy for HCC

Efficacy of target and immunotherapy among different etiologies of aHCC

Gut microbiota and NAFLD/NASH

Closing Remarks

Group photo of all staff